Cargando…
Ratio and index of Neurofilament light chain indicate its origin in Guillain‐Barré Syndrome
OBJECTIVE: Neurofilament light chain (NfL) has been established as a biomarker of axonal damage in many diseases of the central nervous system (CNS). Increased levels of serum NfL (sNfL) can derive as well from damage in the peripheral nervous system (PNS) as from CNS, but little is known about the...
Autores principales: | Körtvelyessy, Peter, Kuhle, Jens, Düzel, Emrah, Vielhaber, Stefan, Schmidt, Christian, Heinius, Annika, Leypoldt, Frank, Schraven, Burkhart, Reinhold, Dirk, Leppert, David, Goihl, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664266/ https://www.ncbi.nlm.nih.gov/pubmed/33030817 http://dx.doi.org/10.1002/acn3.51207 |
Ejemplares similares
-
Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis
por: Ludewig, Susann, et al.
Publicado: (2023) -
Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
por: Diekämper, Elena, et al.
Publicado: (2021) -
CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
por: Pawlitzki, Marc, et al.
Publicado: (2018) -
Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
por: Jacobs, Bart C
Publicado: (2021) -
Blood neurofilament light chain at the doorstep of clinical application
por: Leppert, David, et al.
Publicado: (2019)